Navigation Links
SHARE Program Launched to Address the Challenges of Achieving Blood Pressure Goal
Date:5/15/2009

Survey, please visit: http://www.SHARE-hypertension.com For more information on SHARE and The Challenging Patient, please visit: http://www.sevikar.com andhttp://www.challengingpatient.com References 1. WHO. The world health report 2002 2. Lawes CM, Vander Hoorn S, Rodgers A. Lancet 2008;371(9623):1513-8. 3. Allender et al. European Heart Network 2008 4. Redon etal. 2008 J Hypertens 26(12):S1-S14 5. ESH Scientific Newsletter 2007;8:No 3, http://www.eshonline.org/education/newsletter/2007_03.pdf

6. Neal et al Lancet 2000;356:1955-64, Prospective Studies Collaboration. Lancet 2002;360:1903-13

About DAIICHI SANKYO

DAIICHI SANKYO is a global pharmaceutical company that focuses on researching and marketing innovative medications. The company was created in 2005 through the merger of two traditional Japanese enterprises, Daiichi and Sankyo. With net sales of more than 5.9 billion EUR in fiscal year 2008, DAIICHI SANKYO is one of the world's 20 leading pharmaceutical companies. The company's world headquarters is in Tokyo, and its European base is located in Munich. DAIICHI SANKYO has affiliates in 12 European countries and has been one of the strongest Japanese pharmaceutical companies located in Europe since it set up European production facilities and marketing offices in 1990. The company's research activities focus on the areas of: cardiovascular diseases, hematology, diabetes, anti-infectives and cancer. Its aim is to develop medications that are "best" in their class or to create new classes of pharmaceutical drugs. For more information, please visit: http://www.
'/>"/>

SOURCE DAIICHI SANKYO EUROPE GmbH and SHARE
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Schering-Plough Schedules Webcast For Annual Meeting of Shareholders
2. Arpida Annual General Meeting of Shareholders Approves All Board Proposals
3. Arpida to Discuss Strategy With Shareholders
4. New Website Connects Physicians to Solve Challenging Cases and Share Experiences
5. Syrinx Wins Contract with Leading Pharmaceutical Company for SharePoint 2007 Services
6. Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
7. Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting
8. AEterna Zentaris to Announce First Quarter 2009 Financial and Operating Results and Hold Annual Shareholder Meeting on May 6, 2009
9. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
10. Antiviral Drugmaker Shares Soar as Swine Flu Spreads; Beacon Equity Issues Stock Alerts on: HEB, GNBT, BCRX, DVAX, NVAX, SVA
11. Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 2014  ( www.competitivehealth.com ) — Competitive Health is ... review and advocacy service, has signed an agreement to ... discount health services marketplace. 63% of Americans ... they expected to pay. As part of an ongoing ... Savings is pleased to offer medical bill review and ...
(Date:12/22/2014)... ITRA Global, one of the largest ... real estate, has further expanded its global reach with ... Brisbane, Western Australia, reports Mylinda Vick, CCIM, Chairman of ... Global / ACORPP (Australian Corporate Property and Projects) , ... property services to a wide range of clients in ...
(Date:12/19/2014)... December 19, 2014 Bioject Medical ... and manufacturer of needle-free injection technology, today announced ... Immunomic Therapeutics, Inc. (“ITI”) for ITI to use ... its LAMP™ vaccine platform. , In the ... Worldwide license to the Biojector®-2000 that triggers based ...
(Date:12/19/2014)... 2014 BioPlus Specialty Pharmacy ... the promotion of Nick Maroulis, Pharm.D. to the newly ... , In this position, Dr. Maroulis will continue ... the directors of our multi-site pharmacies as the company ... and during that time he has served in many ...
Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2
... ... Process Optimization Using At-Line Particle Characterization”, will be presented on December 2, 2009. ... the design space and optimize a series of roller compaction runs while varying raw ... ...
... 19 Danish Prince Joachim inaugurated the DONG Energy ... Wednesday, November 18. The facility is one of the ... Genencor,s Accellerase enzymes are used in the plant,s innovative ... of Danisco, was the first to market with commercial ...
... , , BETHESDA, Md., ... innovator in biotechnology for diabetes therapy, and a provider of ... pharmaceutical companies, announced today it closed the previously reported $6.3 ... of its common stock and warrants to purchase up to ...
Cached Biology Technology:Roller Compaction Process Optimization Using At-Line Particle Characterization 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3
(Date:12/10/2014)...  Valencell, a leader in performance biometric data sensor ... from its licensees for highly accurate, clinically validated biometric ... coming from fitness and health sectors, but first responders/military ... is only as useful as the biometric data it ... in long-term mass consumer adoption of wearable products," said ...
(Date:12/10/2014)... December 9, 2014   ... Platform   Jifflenow, ... scheduling solutions for business-to-business (B2B) events, today announced ... in mobile near-field communication (NFC), Bluetooth low energy ... (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , Jifflenow will integrate ...
(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
Breaking Biology News(10 mins):Wearable Technology Products Demand Highly Accurate Biometric Technology 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3
... Harbor Laboratory (CSHL) have discovered how a protein long ... actually triggers this process in cells. The ... enzyme that attaches phosphate molecules to other proteins to ... DDK performs this operation, called phosphorylation, on a protein ...
... in Montreal, made this discovery Montral, January ... researcher at the Institut de recherches cliniques de Montral (IRCM), ... of visual nerves towards the brain. Their findings have been ... Neuroscience . The research was conducted in collaboration with Dr. ...
... traps deep in the Sumatran jungle have captured first-time images ... unique insight into the elusive tiger,s behaviour. After a ... researchers seeking to record tigers in the Sumatran jungle caught ... stopped to sniff and check out the camera trap. ...
Cached Biology News:CSHL scientists uncover role of protein critical for activating DNA replication 2Discovery of a new molecular mechanism that guides visual nerves towards the brain 2Camera traps yield first-time film of tigress and cubs 2Camera traps yield first-time film of tigress and cubs 3
... formulated specifically for Alkaline Phosphatase conjugates. ... activity for both the enzyme and the ... This product has been chemically engineered ... a longer shelf life, resistance to various ...
... The PATH™ Protein Microarray Slide features ... immunoassays. The,PATH™ Slide is the first ... many benefits of nitrocellulose in a ... excellent signal-to-noise ratios. ,The PATH™ ...
... Cassettes facilitate the hybridization of DNA or ... 25mm x 75mm glass slides. The proprietary ... correct for poor flatness, as is often ... low volume chamber (67uL analytical cavity volume) ...
... Mouse monoclonal [3D12] to Lambda Free ... Mixture of light chains of human ... for independent constantly expressed epitope of ... dimer forms of free lambda chains ...
Biology Products: